Nvelop
AI Agents · Cybersecurity
Overview
Nvelop is an AI-native source-to-contract platform that automates RFP generation, vendor evaluation, and compliance tracking for enterprise procurement teams. Founded in 2024 and headquartered in Helsinki, Finland, Nvelop reduces sourcing cycles by 40% through agentic AI.
Funding and backers
Backers
2
Antler, Failup Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 30, 2024
Founded per the company register
Apr 11, 2024
Launched Nvelop launches to deliver gene-editing cargo · Chemical & Engineering News
Registers and programsofficial lists and records that name the company
| Legal entity | Nvelop Technologies Oy | ytj.fi |
| Registered | 30 May 2024 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Olive is the AI-native vendor evaluation platform. Run the full RFP lifecycle — from requirements to vendor selection — in one workspace…
无限光年 INF 是一家面向全球关键行业的 AI 原生科技公司，提供安全可信的 Agentic AI 操作系统与行业应用。.
We help you make the right technology decision the first time. Independent advisory, vendor evaluation, and implementation across CX, AI…
Bravida Finland is the Finnish unit of the Nordic Bravida group, providing installation, service and maintenance of building technical…
Qutwo is a private quantum AI lab in Europe that builds AI to help industry leaders gain a competitive advantage. It partners with large…
Turn every contract into intelligence and that intelligence into action. SimpliContract is an AI-native platform for procurement, finance…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Failup VenturesVia a fund
AntlerVia a fund
1098 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Chroma Medicine, Nvelop Therapeutics merge to form nChroma Bio
Chemical & Engineering News (C&EN): Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.
Read more
Report
Gene-editing field sees another merger, this time between Chroma Medicine and Nvelop Therapeutics
In industry parlance, the deal joins a
Read more
Report
Chroma, Nvelop merge to marry genetic medicine 'cargo' to delivery
The combined company, which will pair Chroma's epigenetic editing with Nvelop's non-viral particles, has raised $75 million from a broad syndicate.
Read more
Report
Nvelop Therapeutics to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference
Company's non-viral DLVR-M platform enables humanized particles for delivery of a wide range of diverse cargoes to a variety of different cell types. Nvelop Therapeutics, a biotechnology company
Read more
Report
Nvelop Therapeutics to Present at the European Society of Gene & Cell Therapy (ESGCT) 31 st Annual Conference
Read more
Report
Nvelop launches to deliver gene-editing cargo
Start-up is using virus-like particles to improve gene therapies
Read more
Report
Report
Report
Nvelop named 9 in Procurement Magazine's Top 10 Start-Ups to Watch, recognised for agentic AI, intelligent sourcing orchestration, and a chat-first interface. Nvelop named 9 in Procurement Magazine's Top 10 Start-Ups to Watch, recognised for agentic AI, intelligent sourcing orchestration, and a chat-first interface.
Nvelop named 9 in Procurement Magazine's Top 10 Start-Ups to Watch, recognised for agentic AI, intelligent sourcing orchestration, and a chat-first interface.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Helsinki
Finland
HQ
Nvelop
Lapinlahdenkatu 16, Helsinki, 00180